Phase II trial of methotrexate-FAM (m-FAM) in adenocarcinoma of unknown primary

Joseph Treat, Steven C. Falchuk, Candide Tremblay, Marc Spielman, Paul V. Woolley, Jacques Rouesse, Dominic Sevin, Thierry Le Chevalier

Research output: Contribution to journal › Article › peer-review

12 Scopus citations

Fingerprint

Dive into the research topics of 'Phase II trial of methotrexate-FAM (m-FAM) in adenocarcinoma of unknown primary'. Together they form a unique fingerprint.

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science